PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

CVC Fund VIII to invest in FutureLife

CVC Capital Partners (CVC), through CVC Capital Partners VIII, is to acquire a co-controlling holding in FutureLife, a pan-European IVF provider, alongside the company’s current investor Hartenberg Holding (Hartenberg).

Headquartered in Prague, Czech Republic, FutureLife is a leading Pan-European provider of IVF and related genetics services, with presence across eight European markets including Czech Republic, Ireland, Netherlands, Finland, Romania and Estonia. FutureLife has 42 well-invested clinics and performs in excess of 39,000 IVF cycles annually, IVF add-on and laboratory services, as well as a series of biological and surgical treatments.
 

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured